HS
HighVista Strategies Portfolio holdings
AUM
$272M
This Quarter Return
+14.9%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$272M
AUM Growth
+$272M
(+4.9%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
27.33%
Holding
177
New
29
Increased
50
Reduced
55
Closed
31
Top Buys
| 1 |
Viridian Therapeutics
VRDN
|
$4.25M |
| 2 |
Advanced Micro Devices
AMD
|
$2.19M |
| 3 |
Celldex Therapeutics
CLDX
|
$2.17M |
| 4 |
Ferguson
FERG
|
$2.15M |
| 5 |
Mineralys Therapeutics
MLYS
|
$2.03M |
Top Sells
| 1 |
Albertsons Companies
ACI
|
$4.15M |
| 2 |
GE Vernova
GEV
|
$3.07M |
| 3 |
SWTX
SpringWorks Therapeutics
SWTX
|
$3.03M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$2.1M |
| 5 |
Bausch Health
BHC
|
$2.03M |
Sector Composition
| 1 | Healthcare | 37.62% |
| 2 | Technology | 22.09% |
| 3 | Industrials | 8.52% |
| 4 | Financials | 6.08% |
| 5 | Consumer Discretionary | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $31.3M | 11.51% | 1,436,136 | – | – |
|
|
2
Viridian Therapeutics
VRDN
$1.5B
| $6.77M | 2.49% | 484,559 +304,008 | +168% | +$4.25M |
|
|
ANSS
3
DELISTED
Ansys
ANSS
| $6.01M | 2.21% | 17,100 +4,300 | +34% | +$1.51M |
|
4
Microsoft
MSFT
$3.77T
| $5.1M | 1.88% | 10,258 +500 | +5% | +$249K |
|
5
Merus
MRUS
$4.98B
| $4.72M | 1.74% | 89,762 +34,723 | +63% | +$1.83M |
|
|
JNPR
6
DELISTED
Juniper Networks
JNPR
| $4.58M | 1.68% | 114,700 | – | – |
|
7
Amazon
AMZN
$2.44T
| $4.14M | 1.52% | 18,893 +200 | +1% | +$43.9K |
|
|
HES
8
DELISTED
Hess
HES
| $4M | 1.47% | 28,900 | – | – |
|
|
AMED
9
DELISTED
Amedisys
AMED
| $3.86M | 1.42% | 39,250 | – | – |
|
10
Nuvalent
NUVL
$5.52B
| $3.85M | 1.41% | 50,460 +10,584 | +27% | +$808K |
|
11
Broadcom
AVGO
$1.4T
| $3.53M | 1.3% | 12,800 -3,100 | -19% | -$855K |
|
12
Western Digital
WDC
$27.9B
| $3.24M | 1.19% | 50,600 +2,300 | +5% | +$147K |
|
13
Akero Therapeutics
AKRO
$3.74B
| $3.2M | 1.18% | 59,993 +35,926 | +149% | +$1.92M |
|
14
Protagonist Therapeutics
PTGX
$3.67B
| $3.2M | 1.18% | 57,851 -20,601 | -26% | -$1.14M |
|
15
Seagate
STX
$35.6B
| $3.19M | 1.17% | 22,100 -900 | -4% | -$130K |
|
16
Core Scientific
CORZ
$4.38B
| $3.07M | 1.13% | 179,900 -19,200 | -10% | -$328K |
|
17
Salesforce
CRM
$245B
| $3.05M | 1.12% | 11,185 +1,900 | +20% | +$518K |
|
18
Immunovant
IMVT
$2.56B
| $2.92M | 1.07% | 182,808 +87,160 | +91% | +$1.39M |
|
19
BridgeBio Pharma
BBIO
$9.89B
| $2.91M | 1.07% | 67,499 +20,999 | +45% | +$907K |
|
20
Xoma
XOMA
$392M
| $2.89M | 1.06% | 114,548 | – | – |
|
21
Enliven Therapeutics
ELVN
$1.2B
| $2.84M | 1.04% | 141,516 +29,057 | +26% | +$583K |
|
22
Praxis Precision Medicines
PRAX
$958M
| $2.83M | 1.04% | 67,288 +28,002 | +71% | +$1.18M |
|
|
VRNA
23
Verona Pharma
VRNA
$9.16B
| $2.73M | 1% | 28,880 +12,179 | +73% | +$1.15M |
|
24
Constellation Energy
CEG
$96.2B
| $2.68M | 0.98% | 8,300 -1,800 | -18% | -$581K |
|
25
XPO
XPO
$15.3B
| $2.66M | 0.98% | 21,080 -5,800 | -22% | -$732K |
|